Introducing Influx™ Fibrant, a New Line of Advanced Allograft. Learn More. >>

Leadership

Isto’s forward-looking operations run under the elite direction of a group of passionate, committed managers who are at the top of their fields.

Senior Management

Don Brown
Chief Executive Officer
Ganfeng Wu
Chief Financial Officer
Brian Barnes, PhD
President
Nathan Taylor
Senior Vice President, Sales & Marketing
Kathy Dlugolecki
Vice President, Human Resources
Neil Kizer, PhD
Vice President, Regulatory & Quality Assurance
Jerry Keefe
Vice President, Operations
Lindsay Murphy
Area Vice President of Sales, East
Jason Slade
Area Vice President of Sales, West
Kenneth Galbraith JD, MPH
General Counsel
© Isto Biologics 2022
SolutionsInQuMagellanInflux FibrantInfluxInflux PLUSInflux SPARCInflux SpongeInforceLightning NeedleBlood Management 
Our companyAboutLeadershipNews & EventsCareers
ResourcesResource CenterPublicationsReferencesComplianceSitemapPrivacy PolicyLegal Disclaimer
AudienceFor PhysiciansFor Hospital AdministratorsFor Distributors
Contact UsContact PageRequest A QuoteFind A Local RepCall Us Today
Isto Biologics is the trade name of a single integrated business group that operates through a number of subsidiaries that includes Arteriocyte Medical Systems, Inc., Isto Technologies II, LLC, Progenicare, LLC, Progenicare Therapeutics, LLC, and Advanced Transfusion Services, LLC.